BioSpace News Archive

Organon (NYSE: OGN) (the “company”), today announced its results for the third quarter ended September 30, 2022.

Akoya Biosciences, Inc., The Spatial Biology Company®, announced that it will be participating in three upcoming investor conferences.

Eyenovia, Inc. announced that the Company will release financial results for the third quarter ended September 30, 2022 on Thursday, November 10, 2022, after the markets close.

RemeGen Co., Ltd., a leading biopharmaceutical company with fully integrated capabilities in research and discovery, clinical development, manufacturing, and commercialization of biologic drugs, will join the event of American Society of Nephrology Kidney Week 2022, hosted from November 3rd. to 6th.

Centogene N.V. announced the global launch of its Biodata Network, a portfolio of data-driven partnering solutions, including Biodata Licenses and Insight Reports, for biopharma and research institutions.

Immunic, Inc. announced financial results for the third quarter ended September 30, 2022 and provided a corporate update.

Regeneron Pharmaceuticals, Inc. announced financial results for the third quarter of 2022 and provided a business update.

Immuneering Corporation announced that management will participate in three November investor conferences to share commentary around the Company’s pipeline, platform, and business strategy.

On Wednesday, Nov. 2, Saint Louis University announced the launch of the Institute for Translational Neuroscience.

Mallinckrodt plc announced that seven scientific abstracts on clinical and health economic outcomes research on treatment with TERLIVAZ® for adult patients with hepatorenal syndrome involving rapid reduction in kidney function,1 an acute and life-threatening condition requiring hospitalization2 will be presented at the American Association for the Study of Liver Diseases 2022 Liver Meeting in Washington, DC, from November 4-8.